Organization
Acasti Pharma, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed

News on Acasti Pharma, Inc.

... LAVAL - Acasti Pharma Inc. ('Acasti' or the 'Company') (NASDAQ: ACST - TSX-V: ACST), today announced ...
... LAVAL - Acasti Pharma Inc. (NASDAQ: ACST - TSX-V: ACST) (the 'Company' or 'Acasti'), a biopharmaceutical innovator ...
... Acasti Pharma Inc. (the Company or Acasti), a biopharmaceutical innovator focused on the research, ...
... LAVAL - Acasti Pharma Inc. ('Acasti' or the 'Company') (NASDAQ: ACST - TSX-V: ACST), today announced ...
... LAVAL - Acasti Pharma Inc. ('Acasti' or the 'Company') (NASDAQ: ACST) (TSX-V: ACST), a biopharmaceutical innovator ...
... LAVAL - Acasti Pharma Inc. ('Acasti' or the 'Company') (NASDAQ: ACST) (TSX-V: ACST), today announced the ...
... Acasti Pharma Announces Annual Performance Grants of Stock Options, Amendment of Stock Option ...
... LAVAL, Québec, July 02, 2018 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. ("Acasti" or the "Company") (NASDAQ:ACST) (TSX-V:ACST), today announced the grant of ...
... Acasti Pharma Inc. reported that its net loss for the quarter ended March 31, ...
... "outperformer" target, his target jumped to $280 from $270. Consensus is $256.57. ACASTI (ACST-TSXVENTURE) CLOSE 95¢, UP 4¢ Citing its development of a potential "best-in ...
Subscribe now for full coverage on Acasti Pharma, Inc.
Start My Free Trial